Pilot study evaluating different methods of circulating tumor DNA quantification in radiation oncology patients
Study on Detecting Cancer DNA in Blood and Urine
Brief description of study.
Detailed description of study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: cancer
-
Age: 18 years - 100 years
-
Gender: All
Inclusion Criteria
Plan to undergo radiation therapy
Exclusion Criteria
Dialysis dependent
This study investigates a new test that aims to detect small pieces of cancer DNA in blood and urine. Cancer DNA, or ctDNA, refers to the genetic material released by cancer cells into the bloodstream. This study looks to improve the detection of ctDNA compared to current methods.
Participants in the study will undergo different procedures to compare ctDNA detection approaches. The study will collect data on how well these methods work in identifying cancer DNA from blood and urine samples.
- Who can participate: Adults who plan to undergo radiation therapy can participate. Individuals who are dependent on dialysis are not eligible.
- Study details: Participants will provide blood and urine samples for the study. These samples will be used to test different methods of detecting cancer DNA, also known as circulating tumor DNA (ctDNA).